Five-Fraction High-Conformal Ultrahypofractionated Radiotherapy for Primary Tumors in Metastatic Breast Cancer

CONCLUSION: In our small dataset, 5-fraction, high-conformal ultrahypofractionated breast RT offered promising 2-year local control with minimal toxicity. Further studies are warranted to investigate the optimal dose and role in this setting.PMID:38529591 | DOI:10.4048/jbc.2024.0004

Source: Journal of Breast Cancer - March 26, 2024 Category: Cancer & Oncology Authors: Jeongshim Lee Jee Hung Kim Mitchell Liu Andrew Bang Robert Olson Jee Suk Chang Source Type: research